Allspring Global Investments’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,852
Closed -$3.31K 2894
2023
Q1
$3.31K Sell
2,852
-1,747
-38% -$3.19K ﹤0.01% 2669
2022
Q4
$12.3K Sell
4,599
-101
-2% -$266 ﹤0.01% 2676
2022
Q3
$13K Buy
+4,700
New +$20K ﹤0.01% 2699
2022
Q2
Sell
-2,155
Closed -$15K 3017
2022
Q1
$15K Buy
2,155
+56
+3% +$463 ﹤0.01% 2957
2021
Q4
$38K Buy
+2,099
New +$45.3K ﹤0.01% 2871

Other funds holding CELL

Allspring Global Investments's CELL Position: Q2 2023 in Review

Allspring Global Investments sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 2,852 shares — an estimated $3.31K sold.

Allspring Global Investments first reported a position in CELL in Q4 2021 and held it in 5 quarters. The position peaked at $38K in Q4 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Allspring Global Investments reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Allspring Global Investments sold 2,852 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $3.31K.
  • Allspring Global Investments first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Allspring Global Investments's PhenomeX Inc. Common Stock position peaked at $38K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Allspring Global Investments's 13F filing for Q2 2023, filed 18 Jul 2023.